CentricsBio Inc
- Biotech or pharma, therapeutic R&D
Antibody product candidate against CD300c can activate Macrophage, and then this Macrophage activate CTL to kill cancer cells(CB301), and also penetrate into brain through BBB to clean up Amyloid beta to treat Alzheimer(CB201). CentricsBio is a preclinical stage company for Alzheimer and cancer therapeutics.
CD300c itself can suppress immune response, and then can be developed as therapeutics against Autoimmune disease(CB101)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}